TrialCancer2019

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

Robin L Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.